Trials / Completed
CompletedNCT03584646
Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver Transplantation
Development and Testing of a Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 21 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
This is a single center, 2-arm, patient-randomized study evaluating the feasibility and potential efficacy of the PRIMER intervention in improving physical function and reducing frailty in adult Liver Transplant candidates. The intervention will consist of a patient-tailored prehabilitation program designed to reduce frailty, improve physical function and nutritional status, and optimize pre- and post-transplant outcomes.
Detailed description
The investigator will pilot-test a two-arm, randomized trial of a prehabilitation intervention in 38 pre-liver transplant patients with End Stage Liver Disease (ESLD). The investigator estimates an attrition rate of 20%, resulting n=30 participants; 10 participants in Arm 1 (control arm) and 20 participants in Arm 2 (intervention arm). To be eligible, patients must be waitlisted or "Penn-Ready" with a MELD-Na less than or equal to 25, English-speaking, able to safely participant in an exercise program, have a smartphone, and be identified as frail. The purpose of this trial is to develop and implement a program of medical optimization, physical activity, and nutrition recommendations specifically tailored to ESLD and designed to reduce frailty, improve physical function, and optimize pre- and post-transplant outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nokia GO Wearable StepTracker | All participants will be provided with a Nokia GO step tracker to monitor daily step counts. The device is not subject to FDA regulation. |
| OTHER | Medication Reminder | Medication reminders are sent to participants in Arm 2 on a daily basis. |
| OTHER | Weekly Check-in appointment with study team or provider | Virtual meeting or telephone call between participants and study team to assess study involvement, adherence to procedures, and following of medical care recommendations. |
Timeline
- Start date
- 2018-02-28
- Primary completion
- 2022-10-01
- Completion
- 2022-10-01
- First posted
- 2018-07-12
- Last updated
- 2023-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03584646. Inclusion in this directory is not an endorsement.